ArticleThe journal of allergy and clinical immunology. Global2026
A computational phenotype for difficult-to-treat asthma with corticosteroid overuse using electronic health care records.
Article in The journal of allergy and clinical immunology. Global, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with difficult-to-treat asthma experience insufficient symptom control despite intensive treatment, leading to overuse of oral corticosteroids (OCSs), which is associated with high patient and economic burden. Many of these remain unnoticed, even by their pulmonologist. Objective: We sought to create a query, also known as computational phenotype, identifying patients with difficult-to-treat asthma to facilitate their access to treatment optimalization. Methods: We used electronic health care records from 2 Dutch hospitals: Franciscus and Admiraal de Ruyter Hospital (Adrz) from the year 2023. We included adult patients with at least 1 hospital visit for asthma. The query was built using Structured Query Language code with data from Franciscus and subsequently applied to data in Franciscus and Adrz. Performance was scored by manual evaluation of the patient records by a pulmonologist and a pharmacist. Results: We included 1217 (Franciscus) and 267 (Adrz) patients. The query classified patients as having difficult-to-treat asthma when they had used high-dose inhaled corticosteroids during at least 90 days and had either received at least 2 courses of high-dose OCSs, or at least 90 days of low-dose OCSs in 2023. The sensitivity, specificity, positive predictive value, and negative predictive value were 0.75, 0.76, 0.63, and 0.85 in Franciscus, and 0.40, 0.95, 0.80, and 0.78 in Adrz, respectively. Conclusions: The query is an efficient way of identifying patients with difficult-to-treat asthma and OCS overuse.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.